| |
| |
|
| Insider
Information: |
Sulat James R |
| Relationship: |
Director |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
1,450,965 |
|
|
Indirect Shares
|
7,334,820 |
|
|
| Direct
Value |
$5,106,080 |
|
|
|
Indirect Value
|
$20,179,083 |
|
|
| Total
Shares |
8,785,785 |
|
|
| Total
Value |
$25,285,163 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -98.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
RR Donnelley & Sons |
RRD |
Officer |
2004-03-02 |
209 |
|
0 |
Premium* |
|
|
Maxygen Inc |
MAXY |
Former CEO & CFO, Dire... |
2013-06-30 |
360,000 |
2013-06-30 |
899 |
Premium* |
|
|
Codexis Inc |
CDXS |
Director, 10% Owner |
2010-04-21 |
666,666 |
2010-04-27 |
5,957,108 |
Premium* |
|
|
Momenta Pharmaceuticals Inc |
MNTA |
Director |
2019-06-20 |
54,090 |
2011-02-14 |
0 |
Premium* |
|
|
AMAG Pharmaceuticals Inc |
AMAG |
Director |
2020-11-16 |
0 |
2014-04-14 |
0 |
Premium* |
|
|
Arch Therapeutics, Inc. |
ARTH |
Director |
2020-06-22 |
370,000 |
2020-06-22 |
1,376,813 |
Premium* |
|
|
Mallinckrodt plc |
MNK |
Director |
2023-11-14 |
0 |
2023-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2019-05-24 |
4 |
OE |
$8.85 |
$88,500 |
D/D |
10,000 |
49,734 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2019-06-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,356 |
54,090 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2020-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,269 |
35,090 |
0 |
- |
|
| ARTH |
Arch Therapeutics, Inc. |
Director |
– • – |
2020-06-22 |
4 |
A |
$81,818.30 |
$2,147,483,647 |
I/I |
454,546 |
1,376,813 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2020-11-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(35,090) |
0 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
26,277 |
52,553 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2023-03-14 |
4 |
B |
$8.42 |
$126,320 |
D/D |
15,000 |
67,553 |
2.39 |
% |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2023-03-15 |
4 |
B |
$8.54 |
$128,156 |
D/D |
15,000 |
82,553 |
2.39 |
% |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2023-06-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(26,277) |
53,122 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2023-06-16 |
4 |
D |
$1.28 |
$4,037 |
D/D |
(3,154) |
79,399 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2023-11-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(53,122) |
0 |
0 |
- |
|
| MAXY |
Maxygen Inc |
CEO & CFO |
• • – |
2012-10-23 |
5 |
GD |
$0.00 |
$0 |
D/D |
40,000 |
360,000 |
0 |
- |
|
37 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
